Investment Thesis — Jabil Inc.
The market is over-extrapolating Jabil's recent strong performance and its strategic shift into higher-value segments, assigning a premium 'tech' multiple to a business fundamentally rooted in contract manufacturing. This overlooks the inherent cyclicality and margin pressures that typically characterize its industry, suggesting an unsustainable valuation.
Catalysts
- Successful divestiture of remaining lower-margin businesses, improving overall profitability mix.
- Significant new contract wins in high-growth, high-margin sectors (e.g., AI infrastructure, advanced medical devices).
- Stronger-than-expected global economic recovery driving increased demand across its diversified portfolio.
Risk Factors
- Global economic slowdown impacting demand for consumer electronics and enterprise hardware.
- Increased competition or pricing pressure in contract manufacturing, eroding margins.
- Supply chain disruptions or rising input costs that cannot be fully passed on to customers.
Key Debates
Jabil's FY25 revenue growth exceeds 10% by Q4.
Fwd P/E expands past 25x by H1 as diversification succeeds.
Analyst PT of $269.75 reached by Q3 on strong results.